Log in to your Inderes Free account to see all free content on this page.
Cinclus Pharma
17.90 SEK
+4.80 %
Less than 1K followers
CINPHA
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Cinclus Pharma
P/B
Median 2024-2025
| 2024 | 2025 | |
|---|---|---|
| Share price (SEK) | 21.38 | 19.26 |
| Shares | 46.5 | 46.5 |
| Market cap | 995.0 | 896.3 |
| Enterprise value | - | - |
| EV/S | - | - |
| EV/EBITDA | - | - |
| EV/EBIT | - | - |
| P/E | neg. | neg. |
| P/B | 1.79 | 2.43 |
| P/S | 217.2 | 15.6 |
| Dividend yield | 0.0 % | 0.0 % |
| Equity ratio | 92.4 % | 67.6 % |
| Gearing ratio | 0.1 % | 2.1 % |
Login required
This content is only available for logged in users